Literature DB >> 17895908

Neuronal HIF-1 alpha protein and VEGFR-2 immunoreactivity in functionally related motor areas following a focal M1 infarct.

Ann M Stowe1, Erik J Plautz, Phuong Nguyen, Shawn B Frost, Ines Eisner-Janowicz, Scott Barbay, Numa Dancause, Anirban Sensarma, Michael D Taylor, Elena V Zoubina, Randolph J Nudo.   

Abstract

Clinical and experimental data support a role for the intact cortex in recovery of function after stroke, particularly ipsilesional areas interconnected to the infarct. There is, however, little understanding of molecular events in the intact cortex, as most studies focus on the infarct and peri-infarct regions. This study investigated neuronal immunoreactivity for hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) receptor-2 (VEGFR-2) in remote cortical areas 3 days after a focal ischemic infarct, as both HIF-1alpha and VEGFR-2 have been implicated in peri-infarct neuroprotection. For this study, intracortical microstimulation techniques defined primary motor (M1) and premotor areas in squirrel monkeys (genus Saimiri). An infarct was induced in the M1 hand representation, and immunohistochemical techniques identified neurons, HIF-1alpha and VEGFR-2. Stereologic techniques quantified the total neuronal populations and the neurons immunoreactive for HIF-1alpha or VEGFR-2. The results indicate that HIF-1alpha upregulation is confined to the infarct and peri-infarct regions. Increases in VEGFR-2 immunoreactivity occurred; however, in two remote regions: the ventral premotor hand representation and the M1 hindlimb representation. Neurons in these representations were previously shown to undergo significant increases in VEGF protein immunoreactivity, and comparison of the two data sets showed a significant correlation between levels of VEGF and VEGFR-2 immunoreactivity. Thus, while remote areas undergo a molecular response to the infarct, we hypothesize that there is a delay in the initiation of the response, which ultimately may increase the 'window of opportunity' for neuroprotective interventions in the intact cortex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17895908      PMCID: PMC3232012          DOI: 10.1038/sj.jcbfm.9600560

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  33 in total

1.  Somatotopic arrangement and corticocortical inputs of the hindlimb region of the primary motor cortex in the macaque monkey.

Authors:  N Hatanaka; A Nambu; A Yamashita; M Takada; H Tokuno
Journal:  Neurosci Res       Date:  2001-05       Impact factor: 3.304

2.  Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain.

Authors:  K L Jin; X O Mao; T Nagayama; P C Goldsmith; D A Greenberg
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

3.  Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.

Authors:  H J Marti; M Bernaudin; A Bellail; H Schoch; M Euler; E Petit; W Risau
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1.

Authors:  Juan C Chavez; Joseph C LaManna
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

5.  Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo.

Authors:  M Milkiewicz; M D Brown; S Egginton; O Hudlicka
Journal:  Microcirculation       Date:  2001-08       Impact factor: 2.628

6.  Collateral growth and angiogenesis around cortical stroke.

Authors:  L Wei; J P Erinjeri; C M Rovainen; T A Woolsey
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

7.  VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain.

Authors:  Z G Zhang; L Zhang; Q Jiang; R Zhang; K Davies; C Powers; N v Bruggen; M Chopp
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

8.  Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor.

Authors:  M Sondell; F Sundler; M Kanje
Journal:  Eur J Neurosci       Date:  2000-12       Impact factor: 3.386

Review 9.  Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration.

Authors:  S D Skaper; F S Walsh
Journal:  Mol Cell Neurosci       Date:  1998-11       Impact factor: 4.314

10.  Temporal profile of angiogenesis and expression of related genes in the brain after ischemia.

Authors:  Takeshi Hayashi; Nobuo Noshita; Taku Sugawara; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2003-02       Impact factor: 6.200

View more
  17 in total

Review 1.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

2.  Gene expression changes of interconnected spared cortical neurons 7 days after ischemic infarct of the primary motor cortex in the rat.

Authors:  Edward T R Urban; Scott D Bury; H Scott Barbay; David J Guggenmos; Yafeng Dong; Randolph J Nudo
Journal:  Mol Cell Biochem       Date:  2012-07-21       Impact factor: 3.396

3.  Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke.

Authors:  Lixia Xue; Hao Chen; Ting Zhang; Jingjiong Chen; Zhi Geng; Yuwu Zhao
Journal:  Metab Brain Dis       Date:  2017-01-16       Impact factor: 3.584

Review 4.  Shaping plasticity to enhance recovery after injury.

Authors:  Numa Dancause; Randolph J Nudo
Journal:  Prog Brain Res       Date:  2011       Impact factor: 2.453

5.  In vitro ischemia suppresses hypoxic induction of hypoxia-inducible factor-1α by inhibition of synthesis and not enhanced degradation.

Authors:  Saravanan S Karuppagounder; Manuela Basso; Sama F Sleiman; Thong C Ma; Rachel E Speer; Natalya A Smirnova; Irina G Gazaryan; Rajiv R Ratan
Journal:  J Neurosci Res       Date:  2013-03-04       Impact factor: 4.164

Review 6.  Vascular endothelial growth factors (VEGFs) and stroke.

Authors:  David A Greenberg; Kunlin Jin
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

Review 7.  Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke.

Authors:  Rachel E Speer; Saravanan S Karuppagounder; Manuela Basso; Sama F Sleiman; Amit Kumar; David Brand; Natalya Smirnova; Irina Gazaryan; Soah J Khim; Rajiv R Ratan
Journal:  Free Radic Biol Med       Date:  2013-01-31       Impact factor: 7.376

8.  Impaired expression of neuroprotective molecules in the HIF-1alpha pathway following traumatic brain injury in aged mice.

Authors:  Joshua Anderson; Rajat Sandhir; Eric S Hamilton; Nancy E J Berman
Journal:  J Neurotrauma       Date:  2009-09       Impact factor: 5.269

Review 9.  Cerebral angiogenesis: a realistic therapy for ischemic disease?

Authors:  David A Greenberg
Journal:  Methods Mol Biol       Date:  2014

10.  Spinal vascular endothelial growth factor (VEGF) and erythropoietin (EPO) induced phrenic motor facilitation after repetitive acute intermittent hypoxia.

Authors:  Erica A Dale; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2012-11-02       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.